Brainsway (BRSYF) Research & Development (2018 - 2026)
Brainsway's (BRSYF) quarterly Research & Development came in at $4.9 million in Q2 2026, down 1.78% on a YoY basis from $4.9 million in Q2 2025, and down 1.58% quarter-over-quarter from $4.9 million in Q1 2026.
Analysis
Brainsway (BRSYF) Research & Development (2018 - 2026) Analysis & Trends
Brainsway (BRSYF) has reported Research & Development for 9 consecutive years, with $4.9 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Research & Development fell 1.78% year-over-year to $4.9 million; the trailing twelve-month figure through Jun 2026 stood at $19.6 million (up 10.92% YoY), and the FY2025 full-year result was $18.9 million, up 16.85% from the prior year.
- Research & Development eased to $4.9 million in Q2 2026 per BRSYF's latest filing, from $4.9 million in the prior quarter.
- Across five years, Research & Development topped out at $5.1 million in Q4 2025 and bottomed at $3.6 million in Q3 2023.
- Historically, Research & Development has averaged $4.4 million across 5 years, with a median of $4.5 million in 2022.
- The sharpest annual moves came in 2022 and 2023: Research & Development jumped 32.5% in 2022, then retreated 24.18% in 2023.
- Over 5 years, Research & Development stood at $4.8 million in 2022, then dropped by 16.65% to $4.0 million in 2023, then increased by 12.96% to $4.5 million in 2024, then climbed by 14.09% to $5.1 million in 2025, then dropped by 4.9% to $4.9 million in 2026.
- According to Business Quant data, Research & Development over the past three periods registered $4.9 million, $4.9 million, and $5.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.55 Bn | 175.95 Bn | 7.27 Bn | 892.00 Mn |
| 2 | Intuitive Surgical | 127.61 Bn | 122.40 Bn | 1.96 Bn | 370.60 Mn |
| 3 | Medtronic | 117.18 Bn | 108.37 Bn | 6.34 Bn | 771.00 Mn |
| 4 | Stryker | 105.17 Bn | 101.69 Bn | 4.50 Bn | 434.00 Mn |
| 5 | Boston Scientific | 64.67 Bn | 64.13 Bn | 3.85 Bn | 554.00 Mn |
| 6 | Edwards Lifesciences | 49.86 Bn | 45.61 Bn | 1.35 Bn | 278.90 Mn |
| 7 | Alcon | 33.06 Bn | 31.60 Bn | 1.68 Bn | -663.00 Mn |
| 8 | Dexcom | 32.22 Bn | 30.27 Bn | 830.00 Mn | 153.00 Mn |
| 9 | Steris | 20.74 Bn | 20.26 Bn | 684.20 Mn | 28.60 Mn |
| 10 | Brainsway | 592.58 Mn | 529.41 Mn | 12.77 Mn | 4.85 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.85 Mn |
| Mar 31, 2026 | 4.93 Mn |
| Dec 31, 2025 | 5.10 Mn |
| Sep 30, 2025 | 4.73 Mn |
| Jun 30, 2025 | 4.94 Mn |
| Mar 31, 2025 | 4.16 Mn |
| Dec 31, 2024 | 4.47 Mn |
| Sep 30, 2024 | 4.11 Mn |
| Jun 30, 2024 | 3.80 Mn |
| Mar 31, 2024 | 3.83 Mn |
| Dec 31, 2023 | 3.96 Mn |
| Sep 30, 2023 | 3.60 Mn |
| Jun 30, 2023 | 3.98 Mn |
| Mar 31, 2023 | 4.91 Mn |
| Dec 31, 2022 | 4.75 Mn |
| Sep 30, 2022 | 4.75 Mn |
| Jun 30, 2022 | 4.55 Mn |
| Mar 31, 2022 | 4.15 Mn |
| Dec 31, 2021 | 4.52 Mn |
| Sep 30, 2021 | 4.04 Mn |